Group items tagged

The Medicine and Healthcare products Regulatory Agency (MHRA) has cautioned men on valproate to talk to their healthcare professional about their treatment, if they want to start a family in the next year. The warning came after a new study, commissioned by the European Medicines Agency, suggested that children fathered by men who took the anti-seizure medicine in the three months prior to conception may be at higher risk of developing neurodevelopmental disorders. Around five in 100 children born to fathers treated with valproate around conception were diagnosed with a neurodevelopmental disorder, compared to three in 100 children whose fathers were taking other antiseizure medicines (lamotrigine or levetiracetam). However, the risk is believed to be much smaller than the risk associated with valproate in pregnancy.

License Look Up Tool acts as your detective, unraveling the mystery and revealing your software's unique identifier. But what exactly is this tool, and how can it help you?By following these steps and understanding the differences between License Lookup Tool QuickBooks Desktop and Online, you should be able to quickly locate your license number or CoID and access the necessary information for your accounting needs. Benefits of the Tool: Recovers Hidden License Numbers: No need for frantic searches; the tool digs deep to unearth the license number residing within your system. Simplifies Activation and Registration: Struggling to activate your software? This tool provides the missing piece to unlock its full potential. Enables Support Access: Contacting Intuit support often requires your license number. The tool ensures you have the necessary information readily available. Facilitates Upgrades and Renewals: Upgrading or renewing your subscription? Having your license number on hand streamlines the process.

Psoriasis vs Eczema, while both causing itchy, inflamed skin, are distinct conditions with different underlying causes and treatments. Understanding these differences is crucial for proper diagnosis and management. Symptoms: Psoriasis: Thick, red, scaly patches: Often on elbows, knees, scalp, but can affect any area. Silvery scales: Easily removed, revealing inflamed skin beneath. Eczema: Dry, itchy, red patches: Often on inner elbows, knees, hands, face, but can be widespread. Fine, scaling: Less prominent compared to psoriasis. Causes: Psoriasis: Autoimmune condition: Immune system mistakenly attacks healthy skin cells, causing rapid growth and buildup. Genetic predisposition: Family history increases risk. Eczema: Atopic dermatitis: Combination of genetic and environmental factors. Dry skin: Major contributing factor. Treatments: Psoriasis: Topical medications: Steroids, retinoids, vitamin D analogues to reduce inflammation and cell growth. Light therapy: Ultraviolet light exposure to slow skin cell production. Eczema: Moisturizers: Regular use hydrates and protects the skin barrier. Emollients: Oil-based creams to soothe dryness and itching. Key Differences: Cause: Psoriasis is autoimmune, while eczema is complex and involves both genetics and environment. Symptoms: Psoriasis typically has thicker scales and less itching, while eczema is drier and itchier.

Recent NHS data sheds light on the evolving landscape of fit note certification, indicating a gradual expansion of roles beyond traditional medical practitioners to pharmacists and nurses. This uptake in numbers coincides with the Department of Work and Pensions's (DWP) call for evidence in relation to fit note reform which will remain open till 8 July 2024. According to figures published by NHS Digital, during the nine-month period from April 2023 to December 2023, pharmacists certified a significant number of fit notes. Approximately 1.4 per cent of fit notes of the 8 million were issued by pharmacists while the rest were issued by the GP surgeries reflecting the impact following legislative amendments in July 2022, which extended certification authority to pharmacists, nurses, occupational therapists, and physiotherapists. In June 2022, the Pharmacists' Defence Association (PDA) advised pharmacists not to sign fit notes where the required therapeutic, diagnostic, or examination skills lie outside their scope of competence. The association remarked that healthcare professionals needed mandatory training under the Health Education England before they are fit to issue fitness notes to the public.

A groundbreaking study analysing data from nearly 600,000 cancer patients in England has shed light on the increased risk of second cancers among breast cancer survivors. The research conducted by University of Cambridge in association with the Lancet Regional Health-Europe studied data from over 580,000 female and over 3,500 male breast cancer survivors diagnosed between 1995 and 2019 using the National Cancer Registration Dataset. The findings suggest that survivors of breast cancer, the most prevalent cancer in the UK, face a substantially higher risk of developing second primary cancers. According to the research, female survivors exhibited a twofold increase in the risk of contralateral breast cancer compared to the general population. The data highlighted an 87 per cent greater risk of endometrial cancer, a 58 per cent greater risk of myeloid leukemia, and a 25 per cent greater risk of ovarian cancer in female survivors.

A recent report from Healthwatch England has highlighted that while people highly value the accessibility of community pharmacies, both in terms of location and prompt service, they also encounter challenges in getting the most out of their pharmacy care experience. The report titled 'Pharmacy: What People' is based on the research conducted by the organisation in November last year, involving 1,650 people who shared their experiences of pharmacy services in England. It showed the country's notable dependence on community pharmacies, with 72 per cent of respondents saying they have used a community pharmacy in the past three months. Usage of online pharmacies is considerably lower than community pharmacies, with only 18 per cent of individuals having used an online pharmacy in the past three months, according to the report published on Tuesday (30 April).

A recent UNISON survey has unearthed disturbing findings regarding the prevalence of sexual harassment among NHS staff across the UK. With data collected from over 12,000 healthcare workers, the survey sheds light on the challenges faced by frontline workers in their workplace environments. Approximately 10 per cent of healthcare professionals reported instances of sexual harassment during their tenure, with nearly 29 per cent of those experiencing harassment also reporting incidents of sexual assault. Shockingly, 50 per cent of respondents reported being leered at or subjected to suggestive gestures, while a quarter faced unwelcome sexual advances or demands for favors. The most common complaint, voiced by 61 per cent of those affected, was the experience of unwanted crude banter or jokes in the workplace.

Certain dental procedures demand a highly specific set of dental skills falling into the realm of dentistry known as oral surgery. Oral surgery addresses a wide array of diseases and conditions related to the gums and teeth.

Independent pharmacy chain, Peak Pharmacy, has sold two of its smaller branches - one in Little Eaton, Derbyshire, and the other in Burton-on-Trent, Staffordshire. Founded in 1981 by Peter and Jane Cattee, Peak Pharmacy has over 150 pharmacies across the UK. The pair of Midlands pharmacies dispense an average of circa 2,800 items per month, according to specialist business property adviser, Christie & Co, which announced the sale. The pharmacy in Burton-on-Trent has been acquired by a local first-time buyer, Mohammed Wasim Gul, while the pharmacy in Little Eaton has been purchased by Amul Telrandhe, who is also the owner of Derwent Pharmacy in Derby.

Community Pharmacy England (CPE) has released a series of resources to help pharmacy owners and their teams promote the new Pharmacy First service, which is slated for launch on 31st January 2024. Pharmacists can use a variety of resources, including posters, social media content, flyers and a local press release, to raise awareness of the new service to patients and members of the public. The promotional materials are now available to download from the Committee's website. "The messaging and graphics have been developed with the input of pharmacists and pharmacy owners, to highlight the benefits of the service to patients, the public, and the NHS," it said. CPE has been providing a range of information, guidance and resources to support community pharmacies in the implementation of the new service. Beginning Monday 29 January 2024, the committee will be hosting a series of online drop-in sessions (no need to register) to assist pharmacy professionals with any queries they may have on the service.

The only way to overcome the challenges facing the medicines supply chain in the UK is through close cooperation - the government, pharmacies, and the industry all working together in tandem - said Andrew Stephenson, Minister for Health and Social Care. The MP for Pendle, Lancashire made the statement while addressing the Healthcare Distribution Association's (HDA) Annual Conference at the Institute of Directors in Pall Mall, London on Thursday (25 January), where over 130 leaders from the pharma industry gathered. As the keynote speaker, Stephenson acknowledged the crucial role wholesalers, manufacturers, and retail pharmacy chains, play in the wellbeing of the nation. He said: "In the first few months that I've been in this job, it's become immediately obvious to me just how important this sector is and just how important the work that all of you do is for our country."

The Royal Pharmaceutical Society (RPS) has called for action on differential degree awarding and registration assessment attainment gaps for Black trainees in initial pharmacy education and training. According to a new report published by the RPS on Tuesday (6 February), there's a pharmacy degree awarding gap of eight per cent and a registration assessment attainment gap of over 22 per cent between Black and White trainees. The variation in pharmacy attainment for Black trainees was first recorded by the General Pharmaceutical Council (GPhC) in 2013, and the Pharmaceutical Journal has been tracking the awarding gap at undergraduate level. Even after a decade, significant differences exist in the awarding and attainment gaps for Black students and trainees compared to their White counterparts, the report said.

The Royal Pharmaceutical Society (RPS), professional membership body for pharmacists and pharmacy, has published its manifesto for the general election, highlighting key issues facing the next government after the election on July 4. Local candidates are urged to recognise and support the vital role pharmacists play in supporting people's health. The RPS teams are gearing up to influence government policy in various crucial areas. Their key asks include: Ensuring Secure Patient Access to Medicines Supporting a Better-Connected NHS Enhancing Accessible Prescribing in Local Communities Maximizing Health Improvement through Locally Accessible Pharmacy Teams Supporting the Workforce to Deliver Patient Care Unlocking the Potential of New Advances in Medicines Supporting the UK's Global Position in Science and Research Acknowledging the efforts of pharmacists and their teams, Professor Claire Anderson, President of the RPS, noted that they are "working incredibly hard to maintain patient access to care amid workforce challenges, medicines shortages and financial pressures."

The Department of Health and Social Care (DHSC) has revised concession prices for four products and confirmed three further price concessions for May 2024. This announcement comes in response to representations made by Community Pharmacy England (CPE) on behalf of community pharmacy owners Concession prices have been redetermined for Ezetimibe 10mg tablets, Quetiapine 100mg tablets, Quetiapine 150mg tablets and Quetiapine 200mg tablets. Here are the newly granted concessions: Nicorandil 10mg tablets (60 tablets): £5.05 Nicorandil 20mg tablets (60 tablets): £9.30 Pregabalin 75mg capsules (56 capsules): £1.54 The revised prices will be applicable to prescriptions submitted for payment during the dispensing month of May 2024, and do not apply to June 2024 prescriptions, the CPE noted.

A new survey by the Royal College of Nursing (RCN) has made a concerning revelation about the rise in nursing students contemplating quitting. Nearly half of nursing students in England are contemplating quitting their courses before completion. This alarming trend threatens the NHS England Long Term Workforce Plan, published a year ago, which aims to significantly expand the nursing workforce by 2036/37. The survey also highlights a dramatic 20 per cent decrease in the number of students enrolling in nursing degree apprenticeships over the past two academic years. This decline underscores the urgency of addressing the challenges faced by nursing students, including increasing financial pressures due to the cost of living, insufficient teaching and supervision, and mental health issues as the primary reasons for consifdering quitting.

The Government has been forced to intervene formally 50 times in the past two years to authorise the use of alternative drugs because of serious medicine shortages hitting patients, new analysis by the National Pharmacy Association (NPA) has found today. 78 per cent of all Serious Shortage Protocols, produced by the Department of Health and Social Care (DHSC) due to medicine shortages, were issued in 2022/24 - more than three times the rate in the previous two years. The NPA, which represents independent community pharmacies in the UK, is warning that shortages are leading to pharmacists having to increasingly turn patients needing vital medication away. Analysis by the NPA of the NHS's Serious Shortage Protocols (SSPs) issued to pharmacies and other providers over the last five years has found that: The number of SSPs issued in the last two years is 3.5 times higher than in the previous two years.

Researchers from King's College London and the University of Helsinki have identified a link between periodontitis (gum disease) and cryptogenic ischemic stroke, which causes a blockage in the blood vessel supplying blood to a region of the brain. The findings, recently published in the Journal of Dental Research, emphasise severe gum disease as a risk factor for young-onset stroke, particularly in patients with no other identifiable risk factors. Dr. Susanna Paju, Periodontology Specialist from the University of Helsinki, led the study in collaboration with Dr. Svetislav Zaric, Clinical Lecturer in Periodontology from King's College London. Dr. Zaric explains the implications of their research: "Stroke remains the second leading cause of death globally. Strikingly, the incidence and prevalence of ischemic stroke have been increasing in the younger population during past decades," she said. "Periodontitis, which involves deep inflammation of the gums due to bacteria under the gumline, can lead to systemic effects as bacteria enter the bloodstream and affect other parts of the body," she added.

Online pharmacy delivery partner Gophr has released new data showing a further drop in pharmacy numbers in England, resulting in a phenomenon they call 'Pharmacy Deserts'. Gophr highlighted that a significant portion of the population now lives in 'pharmacy deserts,' referring to the situation where an increasing number of urban residents struggle to access a shrinking number of pharmacies. For the second consecutive year, Gophr has analysed the data for its 'Prescription For Pressure' initiative. The analysis showed that in 2023, pharmacists dispensed 1.18 billion prescriptions across England, marking an increase of 137 million compared to 2022. The average number of prescriptions per pharmacy stands at 103,380, which equates to 283 a day. As calculated by Gophr's data experts, pharmacy numbers decreased from 11,522 in 2022 to 11,414 in 2023, reflecting a decline of 108 compared to the previous year's 'Prescription For Pressure'. Gophr's data also showed that pharmacy deserts are most prominent in the South East (6,024 people per pharmacy), the East of England (5,327), the South West (5,284), and the Midlands (4,975). London, which ranked high last year, fell out of the top four, with 4,759 people per pharmacy.